Delivery Order SPE2DB22D2006-SPE2DB25FV8VP

Award Date 3/4/25
Potential Completion Date 3/5/25
Potential Value $94K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,436.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,200,000 units of Bicillin L-A, a penicillin-based antibiotic, with a completion date of March 22, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award, valued at $105,967.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,200,000 units of Bicillin L-A, a medication, with an ultimate completion date of October 30, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, valued at $112,824.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 1,200,000 units of Bicillin L-A, a penicillin-based medication, with an ultimate completion date of August 28, 2024. This contract is not associated with any set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This federal contract award, valued at $13,744.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 1,200,000 units of Bicillin L-A, a penicillin medication, with a completion date of January 23, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it was not set aside for any specific business classification. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, valued at $26,624.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 2,400,000 units of Bicillin L-A, a penicillin medication, with a completion date of December 22, 2023. The contract is structured as a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with...
This federal contract award, valued at $2,413.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has no set-aside designation, is a Delivery Order for the supply of 1,200,000 units of Bicillin L-A, a prescription medication. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award, valued at $17,013.66, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,200,000 units of Bicillin L-A, a penicillin-based medication, with a completion date of January 2, 2025. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award, valued at $132,719.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,200,000 units of Bicillin L-A, a penicillin-based medication, to support military healthcare programs. The contract has a completion date of December 11, 2024 and is structured as a firm fixed-price delivery order. Amerisourcebergen holds a significant...
This federal contract award, valued at $29,212.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 1,200,000 units of Bicillin L-A, a penicillin-based medication, with a delivery order issued on September 28, 2024 and an ultimate completion date of September 30, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation....
This federal contract award, worth $25,855.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,200,000 units of Bicillin L-A, a prescription medication, with a completion date of April 30, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The award is part of a larger Indefinite Delivery Contract (IDC) that...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB25FV8VP
    Delivery Order

This federal contract award, valued at $93,830.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,200,000 units of Bicillin L-A, a penicillin-based medication, with a completion date of March 5, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 6/3/25, 9:59 AM